Guest Editorial How to navigate early clinical development and support robust registrational strategy and late-stage development in oncology March 15, 2024Vol.50 No.11By Tanja Obradovic
Guest Editorial Patient navigation, financial toxicity top the agenda as Jill Biden, Kimryn Rathmell visit Atrium Health Wake Forest February 16, 2024Vol.50 No.07By Ruben A. Mesa
Guest Editorial SABCS: 46 years at the forefront of clinical and translational research in breast cancer—and still growing February 16, 2024Vol.50 No.07By Virginia Kaklamani, Srivani Ravoori and Carlos L. Arteaga
Guest Editorial The growing need for cancer patient navigation and how to meet it January 26, 2024Vol.50 No.04By Alyssa Schatz and Crystal S. Denlinger
Guest Editorial Reflecting on Janet Woodcock’s retirement from FDA January 26, 2024Vol.50 No.04By Ellen V. Sigal
FreeGuest Editorial Black leaders in oncology urge the White House to finalize the menthol ban January 19, 2024Vol.50 No.03By Selwyn M. Vickers, Adekunle “Kunle” Odunsi, Alex A. Adjei, John D. Carpten, Robert A. Winn, Taofeek K. Owonikoko, Edith P. Mitchell and Otis W. Brawley
FreeGuest Editorial Biden must stand up to pressure from advocates for menthol–even if they are Black January 19, 2024Vol.50 No.03By Otis W. Brawley
Guest Editorial Weiner: “Unique opportunities in Hawaiʻi are paired with unique challenges” January 12, 2024Vol.50 No.02By George J. Weiner
FreeGuest Editorial Emory Midtown: Architects’ reflections on designing a cancer care center that has never been seen or imagined January 12, 2024Vol.50 No.02By Anthony Treu and Gil May
Guest Editorial How Delaware became a model for improving cancer control, prevention, and treatment January 05, 2024Vol.50 No.01By Nicholas J. Petrelli
